Learning from Every Patient - 6-10 May 2022 ONSITE IN COPENHAGEN & ONLINE WWW.ESTRO.ORG
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
ANNUAL
ESTRO
CONGRESS
Learning from
Every Patient
6-10 May 2022
ONSITE IN COPENHAGEN
& ONLINE
WWW.ESTRO.ORGDEADLINES It is my privilege and great pleasure to invite you to ESTRO 2022
which will take place from 6 to 10 May in Copenhagen, Denmark.
Late-breaking abstract submission:
From 3 to 19 January 2022
The ambition of ESTRO to further reinforce radiation oncology as a core partner in
multidisciplinary cancer care, and to guarantee accessible and high-value radiation
Early registration: therapy for all cancer patients who need it, is expressed in the society’s vision
8 February 2022 statement for 2030: ‘Radiation Oncology. Optimal Health for All, Together.’. After a
difficult couple of years, this is more poignant than ever as, in 2022, we expect to
again be able to freely get together and connect.
Late registration:
6 April 2022 The conference theme is “Learning from every patient”, from the individual to
large cohorts, and will be incorporated throughout the programme. Additionally,
Desk registration: two over-arching topics will be tackled in the six programme tracks. These are
Squamous Cell Carcinomas - what makes them special - and Time - the importance
As of 7 April 2022
of it in radiotherapy.
This year we will optimise the contributions from submitted abstracts. Sessions with
highlights of proffered papers will take place in a plenary setting, offering maximum
visibility to your work. Furthermore, we will give more visibility to quality abstracts by
introducing mini-oral sessions. Taking place in dedicated theatres in the exhibition
area, these sessions will offer you a platform to showcase your achievements. The
interdisciplinary track will also have mini-oral sessions to highlight abstracts which
are of interest to a broad range of disciplines. We will have a Young Scientists Track
encompassing relevant lectures and other activities.
Networking with corporate partners is always invaluable. ESTRO 2022 will host
Europe’s largest industry exhibition in radiation oncology. It will offer you a unique
opportunity to interact with industry leaders and to find out about the latest
Welcome
developments in technology, techniques and oncology products.
We look forward to welcoming you in Copenhagen.
With warm regards,
Ben Slotman
ESTRO 2022 ChairSCIENTIFIC PROGRAMME COMMITTEE SAG FOR RADIATION PHYSICS
PROGRAMME SPOTLIGHT
Ben Slotman (NL) - Chair of the congress Daniela Thorwarth (DE) - Chair
Anna Kirby (UK) - Chair, Interdisciplinary track Marianne Aznar (UK), Jenny Bertholet (CH), In addition to the congress theme of “Learning From Every Patient’,
Ina Jürgenliemk-Schulz (NL) - Chair, SAG Brachytherapy Catharine Clark (UK), Ben Heijmen (NL), Núria
Jornet (ES), Stine Korreman (DK), Guillaume
the two over-arching topics of “Squamous Cell Carcinomas” and
Hans Langendijk (NL) - Chair, SAG Clinical Radiotherapy
Daniela Thorwarth (DE) - Chair, SAG Radiation Physics
Landry (DE), Tufve Nyholm (SE), Christian Richter “Time” will be showcased throughout the programme. The following
(DE), Charlotte Robert (FR), Kathrine Røe Redalen
Maddalena Rossi (NL) - Chair, SAG Radiation Therapy sessions will expand on these topics.
(NO), Marco Schwarz (IT), Kari Tanderup (DK),
Ludwig Dubois (NL) - Chair, SAG Radiobiology
Uulke van der Heide (NL), Wouter van Elmpt
Anne Gasnier (FR) & Laura Mullaney (IE) - Chairs, (NL), Ivan Vogelius (DK)
Young track LEARNING FROM EVERY PATIENT
Umberto Ricardi (IT), Bradley Pieters (NL), Brita
• The Presidential symposium - Learning from every patient
• Education in 2022: Does the patient know better?
Singers Sørensen (DK), Wouter van Elmpt (NL), SAG FOR RADIATION THERAPY
Maria Antonietta Gambacorta (IT), Yat Man • Learning about the patients we do not see: A focus on inequities in radiotherapy
Tsang (UK), Jenny Bertholet (UK), Sophie Perryck Maddalena Rossi (NL) - Chair access and provision
(CH), Jesper Eriksen (DK), Michael Baumann Nigel Anderson (AU), Monica Buijs (NL), Colleen
(DE), Jens Overgaard (DK), Pierre Blanchard Dickie (CA), Aileen Duffton (UK), Maeve Kearney
(FR), Ludvig Muren (DK), Michelle Leech (IE) (IE), Ingrid Kristensen (SE), Michelle Leech (IE), TIME
Sophie Perryck (CH), Yat Man Tsang (UK), Ludwig • MR-guided radiotherapy: How to acquire and interpret imaging data for online
Van den Berghe (BE), Bernd Wisgrill (AT) adaption
SAG FOR BRACHYTHERAPY • Radiation-induced cardiac and vascular toxicity
• Management of radio-recurrent prostate cancer
Ina Jürgenliemk-Schulz (NL) - Chair SAG FOR RADIOBIOLOGY • The radiobiological clock in 2022
Cyrus Chargari (FR), Marisol De Brandere (BE),
• Adapting to changes on different time scales
Peter Hoskin (UK), Nicole Nesvacil (AT), Bradley Ludwig Dubois (NL) - Chair
Pieters (NL), Csaba Polgár (HU), Agata Rembielak Lara Barazzuol (NL), Anna Dubrovska (DE),
(UK), Carl Salembier (BE), Frank-André Siebert Ester Hammond (UK), Fernando Lopez Campos
(DE), Vratislav Strnad (DE), Luca Tagliaferri (IT) (ES), Heidi Lyng (NO), Monica Mangoni (IT),
SQUAMOUS CELL CARCINOMAS
Laure Marignol (IE), Francois Paris (FR), Martin • Toxicity vs tumour control: What makes a good plan?'
Pruschy (CH), Brita Singers Sørensen (DK), • Anal cancer
Marie-Catherine Vozenin (CH) • Changes in disease pattern after the pandemic
SAG FOR CLINICAL RADIOTHERAPY
• HPV-related squamous cell carcinoma: Is it time for de-intensification?
Hans Langendijk (NL) - Chair
Eric Deutsch (FR), Dorota Gabryś (PL), Maria YESTRO
Antoniet ta Gambacor ta (IT ), Mat thias OTHER TOPICS TO BE COVERED IN THE INTERDISCIPLINARY TRACK
Guckenberger (CH), Karin Haustermans (BE), Anne Gasnier (FR) & Laura Mullaney (IE) - Chairs • How can omics lead to personalised radiation oncology?
Peter Hoskin (UK), Florence Huguet (FR), Pedro Jenny Bertholet (CH), Jean-Emmanuel Bibault • Imaging biomarkers for personalised radiotherapy
Lara (ES), Icro Meattini (IT), Marianne Nordsmark (FR), Martin-Immanuel Bittner (DE), Cyrus • Adaptation and automation: The new frontier in radiotherapy
(DK), Remi Nout (NL), Piet Ost (BE), Esther Chargari (FR), Ludwig Dubois (NL), Pierfrancesco • Protons
Troost (DE), Birgitte Vrou Offersen (DK), Joachim Franco (IT), Jolien Heukelom (NL), Sophie Perryck
• Automation in radiotherapy
Widder (AT) (CH), Steven Petit (NL), Kathrine Røe Redalen
• Lethal DNA double strand breaks production: Quality over quantity?
(NO), Mateusz Spałek (PL)
• The role of microbiota in radiotherapy efficacy
• Education in radiation oncology: Advances and opportunities
• Is integration with immunotherapy the new challenge for radiation oncologists?SCIENTIFIC PROGRAMME
FRIDAY 6 MAY 2022
PRE-MEETING COURSE PRE-MEETING COURSE PRE-MEETING COURSE PRE-MEETING COURSE PRE-MEETING COURSE PRE-MEETING COURSE
08:30-17:00 Professional well-being and burn-out Innovative models to assess efficacy Integration of radiotherapy into Real-world implementation of adaptive Time to adapt: Future roles of RTT Skin/cutaneous squamous cell carcinoma
prevention and toxicity treatment combinations targeted or immunotherapy radiotherapy in clinical practice
with radiotherapy
17:15-17:45 OPENING CEREMONY
18:00 OPENING IN EXHIBITION AREA FOLLOWED BY NETWORKING EVENING
SATURDAY 7 MAY 2022
TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE
08:00-08:40 The role of microbiota in The radiobiological clock in Stereotactic radiotherapy: Palliative radiotherapy: Improving radiotherapy Commissioning and quality Monte Carlo dose calculation in Education in 2022: Does the
radiotherapy efficacy 2022 Recent advances Established standards and outcomes for vaginal tumours assurance of commercial in vivo modern day radiotherapy patient know better?
emerging concepts using a joint target concept dosimetry systems
DEBATE DEBATE SYMPOSIUM SYMPOSIUM DEBATE JOINT SYMPOSIUM SYMPOSIUM SYMPOSIUM
Education in radiation This house believes that New developments in the All the hassle with Soft tissue sarcoma: "ESTRO-EFOMP Real-time dose calculation Learning about the patients we
08:45-10:00 oncology: Advances and FLASH radiotherapy is a more treatment of oesophageal hematopoietic systems Brachytherapy and/or EBRT or CT innovations: DECT and do not see: A focus on inequities
opportunities promising avenue for the cancer IORT: Current evidence beyond" in radiotherapy access and
future of radiation oncology provision
than particle radiotherapy
10:00-10:30 COFFEE BREAK
10:30-11:30 PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS
17:15-17:45
PRESIDENTIAL SYMPOSIUM
Learning from every patient
12:45-14:15 LUNCH AND INDUSTRY SYMPOSIA GEC-ESTRO ASSEMBLY
SYMPOSIUM SYMPOSIUM SYMPOSIUM SYMPOSIUM SYMPOSIUM JOINT SYMPOSIUM SYMPOSIUM SYMPOSIUM
Is integration with Emerging radiobiological Large-scale collection of Lymphopenia Preserving brachytherapy skills ESTRO-AAPM Automatic planning: Towards a What’s new in RTT advanced
14:15-15:30 immunotherapy the new modifiers PROs for clinical use during for the future 50 shades of FLASH: From sustainable future practice?
challenge for radiation follow-up experimental beam lines to
oncologists? the clinic
15:30-16:00 COFFEE BREAK
16:00-16:25 E. VAN DER SCHUEREN AWARD
JENS OVERGAARD LEGACY
16:25-16:50
AWARD
MULTIDISCIPLINARY
PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS
16:55-17:55 TUMOUR BOARD
Brain
BEST PRESENTATIONS
18:00-19:00
AWARD CEREMONY
INTERDISCIPLINARY SESSION RADIOBIOLOGY SESSION CLINICAL SESSION PHYSICS SESSION RTT SESSION BRACHYTHERAPY SESSION YESTRO SESSIONSUNDAY 8 MAY 2022
TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE
MR-guided radiotherapy: Mitochondria in tumour and Breast cancer-related Fractionation and biology in Artificial intelligence and Robust treatment planning in Essentials for risk management Less is more: The increasing use
08:00-08:40 How to acquire and interpret normal tissue radiobiology lymphoedema bladder cancer brachytherapy: Current reality particle therapy: of a radiation oncology of hypofractionation in routine
imaging data for online and perspectives Clinical implementation and department clinical practice and its impact
adaption potential pitfalls on patient care
SYMPOSIUM SYMPOSIUM SYMPOSIUM SYMPOSIUM SYMPOSIUM SYMPOSIUM PITCH SESSION SYMPOSIUM
Radiation-induced cardiac Beyond the nucleus: The role Radiotherapy in head 2020 - Losing ground for The use of imaging in prostate Image guidance in particle Every radiotherapy physicist Personalised radiotherapy:
08:45-10:00 and vascular toxicity of mitochondria in radiation and neck advanced disease radiotherapy? brachytherapy therapy: Status and outlook should know about AI/ML... but Improving standards of care
response in surgery with how much? with personalised treatments
reconstruction area
10:00-10:30 COFFEE BREAK
10:30-11:30 PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS
HIGHLIGHTS MULTIDISCIPLINARY TUMOUR BOARD
11:40-12:40
OF PROFFERED PAPERS Oesophageal Cancer
12:45-14:15 LUNCH AND INDUSTRY SYMPOSIA PHYSICS ASSEMBLY
SYMPOSIUM SYMPOSIUM SYMPOSIUM JOINT SYMPOSIUM SYMPOSIUM DEBATE PROFFERED PAPERS SYMPOSIUM
14:15-15:30 Management of radio- The hypoxic tumour Oligometastatic disease ESTRO-IASLC Ocular plaque brachytherapy This house believes that in 10 RTTs and AI: Changing roles
recurrent prostate cancer microenvironment (OMD) Advances in radiotherapy for years particle therapy will be in
lung cancer a better place than now!
15:30-16:00 COFFEE BREAK
16:00-16:25 HONORARY PHYSICIST AWARD
IRIDIUM AWARD
16:25-16:50 In memoriam of Professor
Janusz Skowronek
16:55-17:55 PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS
INTERDISCIPLINARY SESSION RADIOBIOLOGY SESSION CLINICAL SESSION PHYSICS SESSION RTT SESSION BRACHYTHERAPY SESSION YESTRO SESSIONMONDAY 9 MAY 2022
TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE
08:00-08:40 Protons (tbc) Leadership is an action not a position Modern imaging in radiation oncology Biomarkers guiding dose de- U-Net for dummies MRI: From basic to state-of-the- Immobilisation in the rapidly
escalation in HNSCC art acquisition protocols changing world of radiotherapy:
Now and into the future
SYMPOSIUM SYMPOSIUM JOINT DEBATE SYMPOSIUM SYMPOSIUM SYMPOSIUM SYMPOSIUM
Automation in radiotherapy The postive impact of good leadership ESTRO-PROS New era of personalised Deep learning for target auto- Online management of target Online adaptive radiotherapy:
08:45-10:00 This house believes that proton therapy radiotherapy in soft tissue segmentation motion The future is near!
is the standard of care for paediatric sarcomas
patients, adolescents and young adults
requiring radiotherapy
10:00-10:30 COFFEE BREAK
PROFFERED PAPERS SPEED DATING PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS
10:30-11:30
Growing your network
HIGHLIGHTS OF PROFFERED PAPERS MULTIDISCIPLINARY TUMOUR BOARD
11:40-12:40
Paediatric oncology (non-brain)
YOUNG LUNCH SYMPOSIUM
12:45-14:15 LUNCH AND INDUSTRY SYMPOSIA
Increasing the impact of your research
SYMPOSIUM SYMPOSIUM JOINT YMPOSIUM DEBATE SYMPOSIUM SYMPOSIUM DEBATE
Lethal DNA double strand breaks Mobility for radiation oncology ESTRO-EANO This house believes that Challenging the traditional Adapting to changes on different This house believes that
14:15-15:30
production: Quality over quantity? professionals Twists and turns of brain irradiation an intensive follow up for margins for microscopic time scales brachytherapy is a dying art
high-risk breast cancer patients diseases
should be considered
15:30-16:00 COFFEE BREAK
16:00-16:25 K. BREUR AWARD
16:25-16:40 DONAL HOLLYWOOD AWARD
16:45-17:45 PROFFERED PAPERS YOUNG NETWORKING PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS PROFFERED PAPERS
18:00-19:00 GENERAL ASSEMBLY
TUESDAY 10 MAY 2022
TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE TEACHING LECTURE
08:30-09:10 Toxicity vs tumour control: What How can omics lead to personalised Is endometrial cancer ready for treatment Hypofractionation for the Deformable registration for Immunotherapy and Calculating margins correctly:
makes a good plan?' radiation oncology? individualisation based on molecular risk management of postoperative dose accumulation: Current radiotherapy: Basics for Abracadabra with numbers?
factors? PCa status and future challenges physicists
SYMPOSIUM JOINT SYMPOSIUM JOINT SYMPOSIUM SYMPOSIUM SYMPOSIUM SYMPOSIUM SYMPOSIUM
Anal cancer ESTRO-ESR ESTRO-ESGO Fractionation for external beam Medical physicists should be Modelling of complex systems Artificial Intelligence: Friend or
09:15-10:30
Imaging biomarkers for Joint guidelines on the radiation therapy in early breast directly involved in the design, and interactions foe of the RTT?
personalised radiotherapy management of vaginal cancer cancer: State-of-the-art execution and interpretation of
clinical trials
10:30-11:00 COFFEE BREAK
SYMPOSIUM SYMPOSIUM SYMPOSIUM DEBATE SYMPOSIUM SYMPOSIUM SYMPOSIUM
Changes in disease pattern after Adaptation and automation: The HPV-related squamous cell carcinoma: Is it time This house believes that short- Spatial and spatio-temporal Modelling at the voxel level: Changing the radiation medicine
11:00-12:15 the pandemic new frontier in radiotherapy for de-intensification? course radiotherapy is the fractionation Dose and image-data mining paradigm
ideal schedule as part of total
neoadjuvant therapy programs
for rectal cancer
CLOSING SESSION
Which innovations will have the
12:20-13:25 greatest impact in radiotherapy
by 2030?
CLOSING REMARKSESTRO AWARDS
EMMANUEL VAN DER SCHUEREN AWARD HONORARY PHYSICIST AWARD BREUR AWARD LECTURE DONAL HOLLYWOOD AWARD
The Emmanuel van der Schueren Award This award is given at the ESTRO Annual The Breur Award is named after The Hollywood Award is given in the
is given in honour of the founding father Meeting. Previous recipients have been Prof. Klaas Breur one of the founding memory of ESTRO President-Elect
of ESTRO and in recognition of excellent people who, although not physicists, fathers of ESTRO. If he had not died Donal Hollywood, who passed away
scientific work, enormous contribution have made an outstanding contribution prematurely in 1981 he would probably from cancer before taking on the
within ESTRO to the field of education to the cause of physics in ESTRO, by have become ESTRO's first president. duties of President. This annual award
and promotion of radiation oncology as raising the profile of physicists in the Professor Breur was the head of the is given to the best abstract selected
a discipline. The ESTRO Board decides radiation oncology community or to the Radiotherapy Department of the for presentation at an ESTRO congress.
on the recipient of the award. development of the field of physics in Wilhelmina Ziekenhuis van Amsterdam The Scientific Programme Committee
clinical radiotherapy. (Universiteit van Amsterdam) and decides on the recipient of the award
The recipient of this prestigious award delivers a
participated in founding the EORTC. As from all the submitted/accepted
lecture at the ESTRO Annual Meeting. The recipient of this prestigious award delivers a
The Emmanuel van der Schueren Award is
a tribute to Professor Breur’s pioneering abstracts. Selection criteria are based
lecture at the ESTRO Annual Meeting.
published in the Abstract Book of the ESTRO The Honorary Physicist Award is published in
work, ESTRO created this annual “Gold on clarity, supporting data, scientific
Annual Meeting where it is presented. the Abstract Book of the ESTRO Annual Meeting Medal“ award lecture in his name. The rigour, potential significance, interest
where it is presented. Breur Award is the highest honour that in the topic chosen and innovation or
can be conferred on an ESTRO member usefulness, as well as translational work
and is awarded in recognition of the and interdisciplinarity.
JENS OVERGAARD LEGACY AWARD major contribution made by the winner
The recipient of this prestigious award delivers a
GEC-ESTRO IRIDIUM 192 AWARD to European Radiotherapy.
lecture at the ESTRO congress where it is presented
The Jens Overgaard legacy award
The "GEC-ESTRO Iridium Award" is The recipient of this prestigious award delivers a and the lecture is published in the abstract book
recognises his outstanding contribution
presented to the brachytherapist or lecture at the ESTRO Annual Meeting. of the said ESTRO congress.
to promoting scholarly science in
physicist who, in the opinion of the GEC- The Breur Award is published in the Abstract Book
radiation oncology during his 25-year
ESTRO Committee members, has made of the ESTRO Annual Meeting where it is presented.
tenure as Editor-in-Chief of Radiotherapy
& Oncology. a major contribution to the development
of the Brachytherapy speciality.
The recipient of this award delivers a lecture at
the ESTRO annual Meeting. The Jens Overgaard The recipient of this prestigious award delivers a
award is published in the Abstract Book of the lecture at the ESTRO Annual Meeting. LIFETIME ACHIEVEMENT AWARDS HONORARY MEMBERS AWARDS
ESTRO Annual Meeting where it is presented. The GEC-ESTRO Iridium Award is published in
The Lifetime Achievement Awards are The Honorary Members Awards are
the Abstract Book of the ESTRO Annual Meeting
where it is presented. awarded to an ESTRO member who is awarded to outstanding scientific
at the end of their active career and has contributors in the field of oncology. The
contributed tremendously to ESTRO residence of the nominee is worldwide
activities. and not restricted to Europe.MEMBERSHIP 2022
Join the community
The ESTRO membership gives you the tools to improve your daily practice,
develop your career and contribute actively to the progress of radiotherapy,
for the benefit of all cancer patients. Join our ESTRO community and share
our Vision: Radiation Oncology. Optimal Health For All, Together.
As a member of ESTRO and according to your membership category, you will
benefit from many advantages, amongst others:
• Conferences and courses: Access to webcasts, valuable discounts on
registration fees
• Education: Access to ESTRO E-Library, ESTRO publications and guidelines
• Journals: Access to Radiotherapy & Oncology (Green Journal) and open access
journals (ctRO, phiRO, tipsRO), discount on publication fees
• News and networks: Access to ESTRO newsletters, eligibility
for ESTRO mentorship programme
• Societies: Voting rights, eligibility to be part of the Board
of Directors , eligibility for grants and awards To find the
ESTRO membership
ESTRO offers several levels of membership, individual that suits you best,
and collective, with benefits tailored to the needs of each
member and their level of involvement within the Society.
have a look at our ESTRO
Membership Tree on
ESTRO.org/Membership
WWW.ESTRO.ORG6-10 May 2022 ONSITE IN COPENHAGEN & ONLINE Bella Center Entrance 6 Center Boulevard 5, DK-2300 Copenhagen #ESTRO2022 Follow us on www.estro.org
You can also read
